Dynavax Technologies (DVAX) Change in Accured Expenses: 2009-2024
Historic Change in Accured Expenses for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $11.0 million.
- Dynavax Technologies' Change in Accured Expenses fell 377.80% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501,000, marking a year-over-year decrease of 95.97%. This contributed to the annual value of $11.0 million for FY2024, which is 44.30% down from last year.
- Per Dynavax Technologies' latest filing, its Change in Accured Expenses stood at $11.0 million for FY2024, which was down 44.30% from $19.8 million recorded in FY2023.
- In the past 5 years, Dynavax Technologies' Change in Accured Expenses ranged from a high of $39.7 million in FY2021 and a low of -$24.8 million during FY2022.
- For the 3-year period, Dynavax Technologies' Change in Accured Expenses averaged around $2.0 million, with its median value being $11.0 million (2024).
- In the last 5 years, Dynavax Technologies' Change in Accured Expenses soared by 1,316.73% in 2021 and then slumped by 162.40% in 2022.
- Yearly analysis of 5 years shows Dynavax Technologies' Change in Accured Expenses stood at $2.8 million in 2020, then surged by 1,316.73% to $39.7 million in 2021, then crashed by 162.40% to -$24.8 million in 2022, then surged by 179.91% to $19.8 million in 2023, then plummeted by 44.30% to $11.0 million in 2024.